ACE2 and COVID-19: Given its additional role as coronavirus receptor, the relationship between the RAS, its inhibitors, and coronavirus disease 2019 (COVID-19) is currently hotly debated (Danser et al., 2020) and novel treatment options like soluble ACE2 are likely to emerge.